# PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma

> **NCT01502228** · NA · TERMINATED · sponsor: **Indiana University** · enrollment: 14 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DRUG:** 150-Water
- **DRUG:** 62Cu-ethylglyoxal bis
- **PROCEDURE:** Positron Emission Tomography
- **DRUG:** Sunitinib

## Key facts

- **NCT ID:** NCT01502228
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** No further funding
- **Last updated:** 2019-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01502228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01502228, "PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01502228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*